Literature DB >> 27983876

Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models.

Juan Luis García-Rivero1, Cristina Esquinas2, Miriam Barrecheguren2, Marc Bonnin-Vilaplana3, Patricia García-Sidro4, Alberto Herrejón5, Carlos Martinez-Rivera6, Rosa Malo de Molina7, Pedro Jorge Marcos8, Sagrario Mayoralas9, Elsa Naval10, Jose Antonio Ros11, Manuel Valle7, Marc Miravitlles2.   

Abstract

The aim of this study was to identify a multivariate model to predict poor outcomes after admission for exacerbation of chronic obstructive pulmonary disease (COPD).  We performed a multicenter, observational, prospective study. Patients admitted to hospital for COPD were followed up for 3 months. Relevant clinical variables at admission were selected. For each variable, the best cut-offs for the risk of poor outcome were identified using receiver operating characteristic (ROC) curves. Finally, a stepwise logistic regression model was performed. A total of 106 patients with a mean age of 71.1 (9.8) years were included. The mean maximum expiratory volume in the first second (FEV1)(%) was 45.2%, and the mean COPD assessment test (CAT) score at admission was 24.8 (7.1). At 3 months, 39 (36.8%) patients demonstrated poor outcomes: death (2.8%), readmission (20.8%) or new exacerbation (13.2%). Variables included in the logistic model were: previous hospital admission, FEV1 < 45%, Charlson ≥ 3, hemoglobin (Hb)<13 g/L, PCO2 ≥ 46 mmHg, fibrinogen ≥ 554 g/L, C-reactive protein (CRP)≥45 mg/L, leukocyte count < 9810 × 109/L, purulent sputum, long-term oxygen therapy (LTOT) and CAT ≥ 31 at admission. The final model showed that Hb < 13 g/L (OR = 2.46, 95%CI 1.09-6.36), CRP ≥ 45 mg/L (OR = 2.91, 95%CI: 1.11-7.49) and LTOT (3.07, 95%CI: 1.07-8.82) increased the probability of poor outcome up to 82.4%. Adding a CAT ≥ 31 at admission increased the probability to 91.6% (AUC = 0.75; p = 0.001). Up to 36.8% of COPD patients had a poor outcome within 3 months after hospital discharge, with low hemoglobin and high CRP levels being the risk factors for poor outcome. A high CAT at admission increased the predictive value of the model.

Entities:  

Keywords:  CAT; COPD; exacerbations

Mesh:

Substances:

Year:  2016        PMID: 27983876     DOI: 10.1080/15412555.2016.1260538

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  7 in total

1.  Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers.

Authors:  Simona Tabea Huebner; Simona Henny; Stéphanie Giezendanner; Thomas Brack; Martin Brutsche; Prashant Chhajed; Christian Clarenbach; Thomas Dieterle; Adrian Egli; Martin Frey; Ingmar Heijnen; Sarosh Irani; Noriane Andrina Sievi; Robert Thurnheer; Marten Trendelenburg; Malcolm Kohler; Anne Barbara Leuppi-Taegtmeyer; Joerg Daniel Leuppi
Journal:  Respiration       Date:  2021-12-23       Impact factor: 3.966

2.  Risk Factors for Depression in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Kang Xu; Xiu Li
Journal:  Med Sci Monit       Date:  2018-03-08

3.  Chronic Obstructive Pulmonary Disease in Sweden: An intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy.

Authors:  Sten Axelsson Fisk; Shai Mulinari; Maria Wemrell; George Leckie; Raquel Perez Vicente; Juan Merlo
Journal:  SSM Popul Health       Date:  2018-03-20

4.  Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.

Authors:  Marc Miravitlles; Jesús Molina; José Antonio Quintano; Anna Campuzano; Joselín Pérez; Carlos Roncero
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-06

5.  Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease.

Authors:  Yiben Huang; Jianing Wang; Jiamin Shen; Jiedong Ma; Xiaqi Miao; Keke Ding; Bingqian Jiang; Binbin Hu; Fangyi Fu; Lingzhi Huang; Meiying Cao; Xiaodiao Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-26

6.  Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure.

Authors:  Line Hust Storgaard; Hans-Ulrich Hockey; Birgitte Schantz Laursen; Ulla Møller Weinreich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-16

7.  Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.

Authors:  Alexa Nuñez; Viviana Marras; Matevz Harlander; Evgeni Mekov; Cristina Esquinas; Matjaz Turel; David Lestan; Rosen Petkov; Nikolay Yanev; Pietro Pirina; Silvia Negri; Marc Miravitlles; Miriam Barrecheguren
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.